Advertisement

U.S. Markets open in 6 hrs 50 mins

S&P Futures
5,960.00
+1.75(+0.03%)
Dow Futures
43,927.00
+26.00(+0.06%)
Nasdaq Futures
20,915.00
+21.00(+0.10%)
Russell 2000 Futures
2,402.90
-2.90(-0.12%)
Crude Oil
71.66
-0.03(-0.04%)
Gold
2,672.30
-4.00(-0.15%)

Galapagos NV (GLPG.AS)

Amsterdam - Amsterdam Delayed Price. Currency in EUR

25.24

+0.54

(+2.19%)

At close: 05:35PM CET

Loading interactive chart...

GlobeNewswire
Galapagos to Present Results of Pioneering Innovation in Cancer Cell Therapy at ASH 2024
New Phase 1/2 data support the potential of our CAR T-cell therapy candidates, GLPG5101 and GLPG5201, in addressing unmet needs for patients with poor prognoses. Our innovative decentralized cell therapy manufacturing platform delivers fresh, fit cells within a median vein-to-vein time of seven days, with potentially encouraging patient outcomes. Three abstracts, including one oral presentation for GLPG5101 in relapsed/refractory non-Hodgkin lymphoma, and a company showcase, will spotlight our c
Simply Wall St.
Galapagos Third Quarter 2024 Earnings: €0.74 loss per share (vs €0.39 profit in 3Q 2023)
Galapagos ( AMS:GLPG ) Third Quarter 2024 Results Key Financial Results Revenue: €59.8m (down 50% from 3Q 2023). Net...